Skip to main content
SpringerLink
Log in

Uncomon tumours of the nasopharynx

  • Chapter
Management of Rare Adult Tumours

  • 1008 Accesses

Abstract

The main purpose of this chapter is to summarize the current treatment options in patients with uncommon nasopharyngeal tumours where surgical intervention is difficult because of the anatomic localisation. For these cases, radiotherapy is preferred as a treatment option due to surgical difficulty. With that scope, treatment options of nasopharyngeal carcinomas, plasmacytomas, angiofibromas, and minor salivary gland tumours will be discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Refrences

  1. Ali H, Al-Sarraf M (2000) Chemotherapy in advanced nasopharyngeal cancer. Oncology (Huntingt) 14: 1223–30

    CAS  Google Scholar 

  2. Al-Sarraf M, LeBlanc M, Giri PG et al. (1998) Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099. J Clin Oncol 16: 1310–7

    CAS  PubMed  Google Scholar 

  3. Anderson J, Beenken S, Crowe R et al. (1995) Prognostic factors in salivary gland cancer. Head Neck 17: 480–6

    Article  PubMed  Google Scholar 

  4. Baujat B, Audry H, Jean Bourhis J et al. (2006) Chemotherapy in locally advanced nasopharyngeal carcinoma: an individual patient data meta-analysis of eight randomized trials and 1753 patients. Int J Radiat Oncol Biol Phys 64: 47–56

    Article  CAS  PubMed  Google Scholar 

  5. Carrillo JF, Albores O, Ramirez-Ortega MC et al. (2007) An audit of nasopharyngeal fibromas. Eur J Surg Oncol 33: 655–61

    Article  CAS  PubMed  Google Scholar 

  6. Chan AT, Hsu MM, Goh BC et al. (2005) Multicenter, phase II study of cetuximab in combination with carboplatin in patients with recurrent or metastatic nasopharyngeal carcinoma. J Clin Oncol 23: 3568–76

    Article  CAS  PubMed  Google Scholar 

  7. Chan AT, Leung SF, Ngan RK et al. (2005) Overall survival after concurrent cisplatin-radiotherapy compared with radiotherapy alone in loco-regionally advanced nasopharyngeal carcinoma. J Natl Cancer lnst 97: 536–9

    Article  CAS  Google Scholar 

  8. Chan AT, Ma BB, Lo YM et al. (2004) Phase II study of neoadjuvant carboplatin and paclitaxel followed by radiotherapy and concurrent cisplatin in patients with locoregionally advanced nasopharyngeal carcinoma: Therapeutic monitoring with plasma Epstein-Barr virus DNA. J Clin Oncol 22: 3053–60

    Article  CAS  PubMed  Google Scholar 

  9. Cheng SH, Yen KL, Jian JJ et al. (2001) Examining prognostic factors and patterns of failure in nasopharyngeal carcinoma following concomitant radiotherapy and chemotherapy: impact on future clinical trials. Int J Radiat Oncol Biol Phys 50: 717–26

    Article  CAS  PubMed  Google Scholar 

  10. Chi KH, Chang YC, Guo WY (2002) A phase III study of adjuvant chemotherapy in advanced nasopharyngeal carcinoma patients. Int J Radiat Oncol Biol Phys 52: 1238–44

    Article  CAS  PubMed  Google Scholar 

  11. Chua DT, Sham JS, Kwong DL et al. (2003) Treatment outcome alter radiotherapy alone for patients with stage I-II nasopharyngeal carcinoma. Cancer 98: 74–80

    Article  PubMed  Google Scholar 

  12. Chua DT, Sham JS, Kwong PW et al. (2003) Linear accelerator-based stereotactic radiosurgery for limited, locally persistent, and recurrent nasopharyngeal carcinoma: efficacy and complications. Int J Radiat Oncol Biol Phys 56: 177–83

    Article  PubMed  Google Scholar 

  13. Cummings BJ, Blend R, Keane T et al. (1984) Primary radiation therapy for juvenile nasopharyngeal angiofibroma. Laryngoscope 94: 1599–605

    Article  CAS  PubMed  Google Scholar 

  14. Dare AO, Gibbons KJ, Proulx GM et al. (2003) Resection followed by radiosurgery for advanced juvenile nasopharyngeal angiofibroma: report of two cases. Neurosurg 52: 1207–11

    Article  Google Scholar 

  15. Dimopoulos MA, Kiamouris C, Moulopoulos LA (1999) Solitary plasmacytomas of bone and extramedullary plasmacytoma. Hematol Oncol Clin N Am 13: 1249–57

    Article  CAS  Google Scholar 

  16. Dohar JE, Duvall AJ III (1992) Spontaneous regression of juvenile nasopharyngeal angiofibroma. Ann Otol Rhinol Laryngol 101: 469–71

    CAS  PubMed  Google Scholar 

  17. Douglas JG, Laramore GE, Austin-Seymour M et al. (2000) Treatment of locally advanced adenoid cystic carcinoma of the head and neck with neutron radiotherapy. Int J Radiat Oncol Biol Physics 46: 551–7

    Article  CAS  Google Scholar 

  18. El-Banhawy OA, El-Dien AE, Amer T (2004) Endoscopic-assisted midfacial degloving approach for type III juvenile angiofibroma. Int J Pediatr Otolaryngol 68: 21–8

    Article  Google Scholar 

  19. Fee Jr WE, Moir MS, Choi EC et al. (2002) Nasopharyngectomy for recurrent nasopharyngeal cancer: a 2-to 17-year follow-up. Arch Otolaryngol Head Neck Surg 128: 280–4

    PubMed  Google Scholar 

  20. Garden AS, Weber RS, Ang KK et al. (1994) Postoperative radiation therapy for malignant tumors of minor salivary glands. Cancer 73: 2563–9

    Article  CAS  PubMed  Google Scholar 

  21. Guidelines Working Group of the UK Myeloma Forum (UKMF) (2004) Guidelines on the diagnosis and management of solitary plasmacytoma of bone and solitary extramedullary plasmacytoma. Br J Haemato 124: 717–26

    Article  Google Scholar 

  22. Heng DM, Wee J, Fong K et al. (1999) Prognostic factors in 677 patients in Singapore with nondisseminated nasopharyngeal carcinoma. Cancer 86: 1912–20

    Article  CAS  PubMed  Google Scholar 

  23. Herman P, Lot G, Chapot R et al. (1999) Long-term follow-up of juvenile nasopharyngeal angiofibromas: analysis of recurrences. Laryngoscope 109: 140–7

    Article  CAS  PubMed  Google Scholar 

  24. Kam MK, Chau RM, Suen J et al. (2003) Intensity-modulated radiotherapy in nasopharyngeal carcinoma: dosimetric advantage over conventional plans and feasibility of dose escalation. Int J Radiat Oncol Biol Phys 56: 145–57

    Article  PubMed  Google Scholar 

  25. Kuppersmith RB, Theo BS, Donavan DT et al. (2000) The use of intensity modulated radiotherapy for the treatment of extensive and recurrent juvenile angiofibroma. Int J Pediatr Otolaryngol 52: 261–8

    Article  CAS  Google Scholar 

  26. Kwong DL, Sham JS, Au GK et al. (2004) Concurrent and adjuvant chemotherapy for nasopharyngeal carcinoma: a factorial study. Clin Oncol 22: 2643–53

    Article  CAS  Google Scholar 

  27. Langendijk JA, Leemans R, Buter J et al. (2004) The additional value of chemotherapy to radiotherapy in locally advanced nasopharyngeal carcinoma: a meta-analysis of the published literature. J Clin Oncol 22: 4604–12

    Article  CAS  PubMed  Google Scholar 

  28. Laramore GE, Krall JM, Griffin TW et al. (1993) Neutron versus photon irradiation for unresectable salivary gland tumors: final report of an RTOG-MRC randomized clinical trial. Int J Radiat Oncol Biol Phys 27: 235–40

    CAS  PubMed  Google Scholar 

  29. Le QT, Tate D, Koong A et al. (2003) Improved local control with stereotactic radiosurgical boost in patients with nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 56: 1046–54

    Article  PubMed  Google Scholar 

  30. Lee JT, Chen P, Safa A et al. (2002) The role of radiation in the treatment of advanced juvenile angiofibroma. Laryngoscope 112: 1213–20

    Article  PubMed  Google Scholar 

  31. Leung TW, Tung SY, Sze WK et al. (2000) Salvage brachytherapy for patients with locally persistent nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 47: 405–12

    Article  CAS  PubMed  Google Scholar 

  32. Leung TW, Tung SY, Sze WK et al. (2000) Salvage radiation therapy for locally recurrent nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 48: 1331–8

    Article  CAS  PubMed  Google Scholar 

  33. Levendag PC, Lagerwaard FJ, Pan C et al. (2002) High-dose, high-precision treatment options for boosting cancer of the nasopharynx. Radiother Oncol 63: 67–74

    Article  PubMed  Google Scholar 

  34. Liaw CC, Wang CH, Huang JS et al. (1997) Serum lactate dehydrogenase level in nasopharyngeal carcinoma. Acta Oncol 36: 159–64

    Article  CAS  PubMed  Google Scholar 

  35. Liebross RH, Ha CS, Cox JD et al. (1999) Clinical course of solitary extramedullary plasmacytoma. Radiother Oncol 52: 245–49

    Article  CAS  PubMed  Google Scholar 

  36. Ma BB, Chan AT (2005) Recent perspectives in the role of chemotherapy in the management of advanced nasopharyngeal carcinoma. Cancer 103: 22–31

    Article  PubMed  Google Scholar 

  37. Ma J, Mai HQ, Hong MH (2001) Results of a prospective randomized trial comparing chemotherapy plus radiotherapy with radiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma. J Clin Oncol 19: 1350–7

    CAS  PubMed  Google Scholar 

  38. Marshall AH, Bradley PJ (2006) Management dilemmas in the treatment and follow-up of advanced juvenile nasopharyngeal angiofibroma. ORL J Otorhinolaryngol Relat Spec 68: 273–8

    PubMed  Google Scholar 

  39. McAfee WJ, Morris CG, Amdur RJ et al. (2006) Definitive radiotherapy for juvenile nasopharyngeal angiofibroma. Am J Clin Oncol 29: 168–70

    Article  PubMed  Google Scholar 

  40. Mendenhall WM, Mendenhall CM, Mendehall NP (2003) Solitary plasmacytoma of bone and soft tissues. Am J Otolaryngol 24: 395–9

    Article  PubMed  Google Scholar 

  41. Mendenhall WM, Morris CG, Amdur RJ et al. (2004) Radiotherapy alone or combined with surgery for adenoid cystic carcinoma of the head and neck. Head Neck 26: 154–62

    Article  PubMed  Google Scholar 

  42. Michalaki VJ, Hall J, Henk JM et al. (2003) Definitive radiotherapy for extra-medullary plasmacytomas of the head and neck. Br J Radiol 76: 738–41

    Article  CAS  PubMed  Google Scholar 

  43. Miller FR, Lavertu P, Wanamaker JR, et al. (1998) Plasmacytomas of the head and neck. Otolaryngo Head Neck Surg 119: 614–8

    Article  CAS  Google Scholar 

  44. Nicolai P, Berlucchi M, Tomenzoli D et al. (2003) Endoscopic surgery for juvenile angiofibroma: when and how. Laryngoscope 113: 775–82

    Article  PubMed  Google Scholar 

  45. Onerci TM, Yucel OT, Ogretmenoglu O (2003) Endoscopic survey in treatment of juvenile nasopharyngeal angiofibroma. Int J Pediatr Otolaryngol 67: 1219–25

    Article  Google Scholar 

  46. Ozyar E, Selek U, Laskar S et al. (2006) Treatment results of 165 pediatric patients with non-metastatic nasopharyngeal carcinoma: A Rare Cancer Network study. Radiother Oncol 81: 39–46

    Article  PubMed  Google Scholar 

  47. Ozyar E, Yildiz F, Akyol F et al. (2002) Adjuvant high-dose-rate brachytherapy after external beam radiotherapy in nasopharyngeal carcinoma. Int J. Radiat Oncol Biol Phy 52: 101–8

    Article  Google Scholar 

  48. Poon D, Yap SP, Wong ZW et al. (2004) Concurrent chemoradiotherapy in locoregionally recurrent nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 59: 1312–8

    Article  PubMed  Google Scholar 

  49. Pryor SG, Moore EJ, Kasperbauer JL (2005) Endoscopic versus traditional approaches for excision of juvenile nasopharyngeal angiofibroma. Laryngoscope 115: 1201–7

    Article  PubMed  Google Scholar 

  50. Reddy KA, Mendenhall WM, Amdur RJ et al. (2001) Long-term results of radiation therapy for juvenile nasopharyngeal angiofibroma. Am J Otolaryngol 22: 172–5

    Article  CAS  PubMed  Google Scholar 

  51. Reddy SP, Raslan WF, Gooneratne S et al. (1995) Prognostic significance of keratinization in nasopharyngeal carcinoma. Am J Otolaryngol 16: 1038

    Article  Google Scholar 

  52. Schick B, Urbschat S (2004) New aspects of pathogenesis of juvenile angiofibroma. Hosp Med 65: 269–73

    PubMed  Google Scholar 

  53. Schramm VL, Imola MJ et al. (2001) Management of Nasopharyngeal Salivary Gland Malignancy. Laryngoscope 111(9): 1533–44

    Article  PubMed  Google Scholar 

  54. Soutar R, Lucraft H, Jackson G et al. (2004) Guidelines on the diagnosis and management of solitary plasmacytoma of bone and solitary extramedullary plasmacytoma. Clin Oncol (R Coll Radiol) 16: 405–13

    Google Scholar 

  55. Strojan P, Soba E, Lamovec J, et al. (2002) Extramedullary plasmacytoma: Clinical and histopathologic study. Int J Radiat Onco Biol Phys 53: 692–701

    Article  Google Scholar 

  56. Sze WM, Lee AW, Yau TK et al. (2004) Primary tumor volume of nasopharyngeal carcinoma: prognostic significance for local control. Int J Radiat Oncol Biol Phys 59: 21–7

    Article  PubMed  Google Scholar 

  57. Teo PM, Leung SF, Chan AT et al. (2000) Final report of a randomized trial on altered-fractionated radiotherapy in nasopharyngeal carcinoma prematurely terminated by significant increase in neurologic complications. Int J Radiat Oncol Biol Phys 48: 1311–22

    Article  CAS  PubMed  Google Scholar 

  58. Teo PM, Leung SF, Lee WY et al. (2000) Intracavitary brachytherapy significantly enhances local control of early T-stage nasopharyngeal carcinoma: The existence of a dose-tumour-control relationship above conventional tumoricidal dose. Int J Radiat Oncol Biol Phys 46: 445–58

    Article  CAS  PubMed  Google Scholar 

  59. Tournier-Rangeard L, Lapeyre M, Graff-Caillaud P et al. (2006) Radiotherapy for solitary extramedullary plasmacytoma in the head-and-neck region: A dose greater than 45 Gy to the target volume improves the local control. Int J Radiat Oncol Biol Phys 64: 1013–7

    Article  PubMed  Google Scholar 

  60. Turen S, Ozyar E, Altundag K et al. (2007) Serum Lactate Dehydrogenase Level is a Prognostic Factor in Patients with Locoregionally Advanced Nasopharyngeal Carcinoma Treated with Chemoradiotherapy. Cancer Invest 25: 315–21

    Article  CAS  PubMed  Google Scholar 

  61. Wei WI, Sham JS (2005) Nasopharyngeal carcinoma. Lancet 365: 2041–54

    Article  PubMed  Google Scholar 

  62. Wei WI, Mok VW (2007) The management of neck metastases in nasopharyngeal cancer. Curr Opin Otolaryngol Head Neck Surg 15: 99–102

    Article  PubMed  Google Scholar 

  63. Wein OR, Popat SR et al. (2002) Plasma cell tumors of the skull base: Four case reports and literature review. Skull Base: An Interdisciplinary Approach 12: 77–86

    Article  Google Scholar 

  64. Windfyhn J, Ott G (2002) Extramedullary plasmacytoma manifesting a palpable mass in the nasal cavity. Ear Nose Throat J 81(2): 110–14

    Google Scholar 

  65. Wu WW, Kwong DL, Sham JS (2004) Target dose conformity in 3 dimensional conformal radiotherapy and intensity modulated radiotherapy. Radiother Oncol 71: 201–6

    Article  CAS  PubMed  Google Scholar 

  66. Yan JH, Xu GZ, Hu YH et al. (1990) Management of local residual primary lesion of nasopharyngeal carcinoma: II. Results of prospective randomized trial on booster dose. Int J Radiat Oncol Biol Phys 18: 295–8

    Article  CAS  PubMed  Google Scholar 

Download references

Authors
  1. E. Özyar
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. Gültekin
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Hôpital Henri-Mondor, 51, avenue du Maréchal-de-Lattre-de-Tassigny, 94000, Créteil Cedex, France

    Yazid Belkacémi MD PhD (Professor Radiation Oncology, Deputy Head of the Department of Radiation Oncology) (Professor Radiation Oncology, Deputy Head of the Department of Radiation Oncology)

  2. Centre hospitalier universitaire Vaudoir, Rue du Bugnon, CH-1011, Lausanne, Switzerland

    René-Olivier Mirimanoff MD (Professeur Radiation Oncology, Head of the Department of Radiation Oncology) & Mahmut Ozsahin MD PhD (Associate Professor in the Department of Radiation Oncology) (Professeur Radiation Oncology, Head of the Department of Radiation Oncology) &  (Associate Professor in the Department of Radiation Oncology)

Rights and permissions

Reprints and permissions

Copyright information

© 2009 Springer-Verlag France, Paris

About this chapter

Cite this chapter

Özyar, E., Gültekin, M. (2009). Uncomon tumours of the nasopharynx. In: Belkacémi, Y., Mirimanoff, RO., Ozsahin, M. (eds) Management of Rare Adult Tumours. Springer, Paris. https://doi.org/10.1007/978-2-287-92246-6_10

Download citation

  • DOI: https://doi.org/10.1007/978-2-287-92246-6_10

  • Publisher Name: Springer, Paris

  • Print ISBN: 978-2-287-92245-9

  • Online ISBN: 978-2-287-92246-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation